AEROMICS
Aeromics is a clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke. A paradigm shift in its understanding of water physiology was the discovery aquaporins, proteins that form water channels to allow water into and out of cells, by Peter Agre (2003 Nobel Prize in Chemistry). Despite the vital role of aquaporins in maintaining water homeostasis and its implications in various disease states, therapeutic agents targeting aquaporins have until now remained elusive. Aeromics’ drug candidate, AER-271, targets aquaporin-4 (AQP4), the primary water channel in the brain, and has best-in-class credentials for acute intravenous therapy for stroke-related cerebral edema (CE).
AEROMICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2006-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.aeromics.com
Total Employee:
1+
Status:
Active
Contact:
216-772-1004
Email Addresses:
[email protected]
Total Funding:
12.61 M USD
Technology used in webpage:
Viewport Meta SSL By Default LetsEncrypt Content Delivery Network Euro Typekit Squarespace Squarespace Hosted 1and1 Email Solutions
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Series A - Aeromics
Broadview Ventures
Broadview Ventures investment in Debt Financing - Aeromics
Official Site Inspections
http://www.aeromics.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Aeromics"
Aeromics
For its initial drug target Aeromics chose Aquaporin-4, which is situated at the blood brain barrier and the primary route by which water enters the brain. If successful with an Aquaporin-4 …See details»
Aeromics Company Profile 2024: Valuation, Funding & Investors
Aeromics General Information Description. Developer of an anti-edema therapy designed to treat patients affected by acute central nervous system edema. The company's therapy is based on …See details»
our team - Aeromics
Mr. Draime served as Aeromics’ Chairman from October 2017 to July 2020. Jeff is the son of D.M. Draime, the founder of Stoneridge, Inc. (NYSE: SRI) and has served in various roles with …See details»
Aeromics LLC: Contact Details and Business Profile - RocketReach
Aeromics LLC is a Biotechnology, Pharmaceuticals, and Drug Discovery company_reader located in Cleveland, Ohio with $1 million in revenue and 6 employees. Find top employees, contact …See details»
Aeromics - Overview, News & Similar companies | ZoomInfo.com
Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company developing first-in-class anti-edema therapies, announced today the appointment of …See details»
Aeromics - Products, Competitors, Financials, Employees, …
Aeromics is a clinical-stage pharmaceutical company focused on developing therapeutics based on water physiology to address severe ischemic stroke and other conditions. The company's …See details»
Aeromics - Company Profile - Tracxn
Aeromics - Development of therapeutics based on water physiology to treat CNS edema. Raised a total funding of $14.1M over 5 rounds from 4 investors. Founded by Marc Pelletier and …See details»
AEROMICS, Inc. Company Profile | Branford, CT - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AEROMICS, Inc. of Branford, CT. Get the latest business insights from Dun & Bradstreet.See details»
Aeromics - Crunchbase
Aeromics is a clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke.See details»
Aeromics Company Profile - Office Locations, Competitors ... - Craft
Aeromics is a clinical-stage pharmaceutical company that specializes in anti-edema therapies. It develops an intravenously administered aquaporin-4 (AQP4) inhibitor (AER-271) for severe, …See details»
Aeromics - Funding, Financials, Valuation & Investors - Crunchbase
Aeromics is funded by 2 investors. Connecticut Innovations and Broadview Ventures are the most recent investors. Aeromics has a post-money valuation in the range of $1M to $10M as of Mar …See details»
Aeromics Company Profile | Management and Employees List
Find contact information for Aeromics. Learn about their Manufacturing market share, competitors, and Aeromics's email format.See details»
Aeromics CEO and Key Executive Team | Craft.co
Aeromics's Director is Peter Agre. Other executives include Paul R McGuirk, Chief Technology Officer; Joseph Schindler, Chief Medical Officer and 2 others. See the full leadership team at …See details»
Aeromics - Broadview Ventures
Aeromics is a clinical stage drug development company developing Aquaporin inhibitors for the treatment of cerebral edema in stroke, based on pioneering discoveries by Dr. Peter Agre …See details»
Expanded Access Policy - Aeromics
Aeromics believes that participation in our clinical trial will be the most appropriate way to access our lead experimental therapy, AER-271, and therefore we are not making it available under …See details»
Aeromics - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Aeromics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... We're working on getting contact data for Aeromics . …See details»
Aeromics founded to control edema - BioCT
Aeromics founded to control edema Marc F. Pelletier arrived in New Haven for a postdoctoral fellowship at Yale in 2002, knowing he wanted to form a biotech company “that would make …See details»
Aeromics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Aeromics uses 10 technology products and services including HTML5, Lightbox, and DigiCert, according to G2 Stack. Aeromics is actively using 14 technologies for its website, according to …See details»
PR 08/16/18 Directors - Aeromics
BRANFORD, CONN., AUG. 16,2018 – Aeromics, Inc. (“Aeromics” or “the Company”), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema, or brain …See details»